WallStSmart

Akso Health Group ADR (AHG)vsCardinal Health Inc (CAH)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Cardinal Health Inc generates 1838028% more annual revenue ($254.25B vs $13.83M). CAH leads profitability with a 0.7% profit margin vs -135.0%. CAH earns a higher WallStSmart Score of 55/100 (C).

AHG

Avoid

15

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 5.3Quality: 9.0
Piotroski: 5/9Altman Z: 12.00

CAH

Buy

55

out of 100

Grade: C

Growth: 7.3Profit: 4.5Value: 4.0Quality: 7.5
Piotroski: 6/9Altman Z: 4.52
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AHGUndervalued (+10.2%)

Margin of Safety

+10.2%

Fair Value

$1.57

Current Price

$0.75

$0.82 discount

UndervaluedFair: $1.57Overvalued
CAHSignificantly Overvalued (-28.8%)

Margin of Safety

-28.8%

Fair Value

$175.31

Current Price

$220.11

$44.80 premium

UndervaluedFair: $175.31Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AHG2 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
12.0010/10

Safe zone — low bankruptcy risk

CAH5 strengths · Avg: 9.4/10
EPS GrowthGrowth
68.8%10/10

Earnings expanding 68.8% YoY

Debt/EquityHealth
-3.4510/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.5210/10

Safe zone — low bankruptcy risk

Market CapQuality
$52.42B9/10

Large-cap with strong market position

Free Cash FlowQuality
$1.43B8/10

Generating 1.4B in free cash flow

Areas to Watch

AHG4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$634.05M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-89.4%2/10

ROE of -89.4% — below average capital efficiency

Revenue GrowthGrowth
-12.9%2/10

Revenue declined 12.9%

CAH4 concerns · Avg: 3.3/10
P/E RatioValuation
31.2x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
0.7%3/10

0.7% margin — thin

Operating MarginProfitability
1.3%3/10

Operating margin of 1.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : AHG

The strongest argument for AHG centers on Debt/Equity, Altman Z-Score.

Bull Case : CAH

The strongest argument for CAH centers on EPS Growth, Debt/Equity, Altman Z-Score. PEG of 1.13 suggests the stock is reasonably priced for its growth.

Bear Case : AHG

The primary concerns for AHG are EPS Growth, Market Cap, Return on Equity.

Bear Case : CAH

The primary concerns for CAH are P/E Ratio, Return on Equity, Profit Margin. Thin 0.7% margins leave little buffer for downturns.

Key Dynamics to Monitor

AHG profiles as a turnaround stock while CAH is a value play — different risk/reward profiles.

CAH carries more volatility with a beta of 0.52 — expect wider price swings.

CAH is growing revenue faster at 5.8% — sustainability is the question.

CAH generates stronger free cash flow (1.4B), providing more financial flexibility.

Bottom Line

CAH scores higher overall (55/100 vs 15/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Akso Health Group ADR

HEALTHCARE · MEDICAL DISTRIBUTION · China

Akso Health Group ADR is a leading entity in the healthcare sector, dedicated to providing innovative medical solutions and comprehensive patient care services. With a strong emphasis on advanced health technologies, the company is strategically positioned in the telehealth and personalized medicine markets, supported by a robust research and development framework. As it navigates the rapidly evolving healthcare landscape, Akso Health Group presents an attractive investment opportunity for institutional investors seeking to capitalize on transformative trends within the industry.

Visit Website →

Cardinal Health Inc

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Cardinal Health, Inc. is an American multinational health care services company.

Visit Website →

Want to dig deeper into these stocks?